A lung cancer care team at Fox Chase Cancer Center and Temple University Health System, both based in Philadelphia, has received the North American Cancer Care Team Award from the International Association for the Study of Lung Cancer.

Melanoma rates have been steadily declining among younger generations over the past two decades, according to a study published Nov. 15 in the Journal of the American Academy of Dermatology.

Baptist Health plans to expand its cancer care services with the opening of a standalone cancer center in Key West, Fla.

Cancer centers across the U.S. are continually developing innovative solutions to address growing cancer care gaps. These solutions often include increasing access to valuable cancer trials or highly targeted screening initiatives. 

The rise in pancreatic cancer diagnoses can be attributed to previously undetected disease and not a rise in cancer occurrence, according to a study published Nov. 19 in the Annals of Internal Medicine.

Sacramento, Calif.-based UC Davis Health has permanently named David Cooke, MD, as physician-in-chief for the UC Davis Comprehensive Cancer Center. 

The global cancer burden of adolescents and young adults is projected to increase by approximately 12% by 2050, according to a Nov. 15 study published in The Lancet Oncology. 

Penn Medicine Lancaster (Pa.) General Health has named Efrat Dotan, MD, as executive medical director of the Ann B. Barshinger Cancer Institute.

Compared to primary care physicians, dermatologists have 13.3-fold higher accuracy when diagnosing melanoma using dermoscopic images, according to a study published Nov. 13 in JAMA Dermatology. 

Bryan Bell, MD, DDS, has accepted the roles of executive medical director of Providence Cancer Institute and director of its research arm, the Earle A. Chiles Research Institute, both based in Portland, Ore., according to a news release shared with Becker's. 

The University of Chicago Medicine Comprehensive Cancer Center has partnered with the Energy Department to harness the technology of the department's Argonne National Laboratory toward the development of treatments for drug-resistant cancers.

Researchers from Chicago-based Northwestern Medicine Canning Thoracic Institute found that the COVID-19 virus triggers the development of a unique immune cell with anti-cancer properties, it said in a Nov. 15 system news release.

Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer.

When diagnosed with prostate cancer, men with limited life expectancy are being overtreated, according to a study published Nov. 11 in JAMA Internal Medicine. 

Among the many factors at play in overcoming cancer care gaps in the U.S., increased screening and access to care are top of mind. However, cancer trial participation is also crucial. 

An FDA advisory panel endorsed a minimally invasive breast cancer surgery alternative at a Nov. 7 meeting. 

Research and innovation have steadily driven advancements in breast cancer screening since Congress enacted the Mammography Quality Standards Act in 1992. 

Houston-based University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery & Innovation. Research at the institute will focus on immunology and cell engineering with the purpose of creating new treatments for cancer and autoimmune disease.

Altamonte Springs, Fla.-based AdventHealth has launched a pilot program designed to harness AI to assess a patient's risk of developing breast cancer. 

A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial.